Search results
Jardiance vs. Farxiga: Similarities and Differences
Verywell Health via Yahoo News· 2 months agoLearn more about the similarities and differences between Jardiance (empagliflozin) and Farxiga (dapagliflozin), two SGLT2 inhibitors used for treating...
Is Eli Lilly Stock A Buy Or A Sell As FDA Plans Meeting To Discuss Alzheimer's Drug?
Investor's Business Daily· 6 hours agoEli Lilly stock yo-yoed over the last week after announcing the Food and Drug Administration has...
Pharma Stock Roundup: JNJ Q4 Results Mixed, MRK Keytruda Prostate Cancer Study Ends
Zacks via Yahoo Finance· 1 year agoThis week, J&J JNJ began the fourth-quarter earnings season for the drug and biotech sector with...
Eli Lilly (LLY) to Report Q3 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 6 months agoEli Lilly & Company LLY will report third-quarter 2023 results on Nov 2, before market open. In the...
There’s a New Weight-Loss Drug Called Zepbound. Really? Zepbound?
Slate via Yahoo News· 6 months agoThis week, the world simultaneously got yet another weight-loss drug and a reason to wonder why...
Decoding Eli Lilly and Co (LLY): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 1 week agoStrengths: Robust product pipeline and strong performance of key products. Weaknesses: High...
Biden targets diabetes drug Jardiance, blood thinner Eliquis, and 8 others for controversial...
Fortune via Yahoo Finance· 8 months agoThe move is expected to cut costs in a few years for some patients but faces litigation from the...
Eli Lilly Says Q3 Earnings Supported By Key Products and Volume, Cuts FY22 Outlook
Benzinga via Yahoo Finance· 2 years agoEli Lilly And Co (NYSE: LLY) has reported Q3 sales of $6.94 billion, +2% Y/Y beating the consensus...
8 Pharma Stocks Affected by New Drug Price Negotiation Rules
Motley Fool· 8 months agoAbout a year ago, President Joe Biden signed the Inflation Reduction Act into law. Among the many...
Medicare's drug pricing list didn't impact company stocks — here's why
Yahoo Finance· 8 months agoInvestor sentiment was indifferent towards the historic announcement Tuesday by the Biden...